JP2022514835A5 - - Google Patents
Info
- Publication number
- JP2022514835A5 JP2022514835A5 JP2021534266A JP2021534266A JP2022514835A5 JP 2022514835 A5 JP2022514835 A5 JP 2022514835A5 JP 2021534266 A JP2021534266 A JP 2021534266A JP 2021534266 A JP2021534266 A JP 2021534266A JP 2022514835 A5 JP2022514835 A5 JP 2022514835A5
- Authority
- JP
- Japan
- Prior art keywords
- cysteine
- insulin
- acid
- composition according
- glutamic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024147410A JP2024178193A (ja) | 2018-12-21 | 2024-08-29 | インスリン及びグルカゴンを含む薬学組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2018-0167798 | 2018-12-21 | ||
| KR20180167798 | 2018-12-21 | ||
| PCT/KR2019/018320 WO2020130751A1 (ko) | 2018-12-21 | 2019-12-23 | 인슐린 및 글루카곤을 포함하는 약학 조성물 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024147410A Division JP2024178193A (ja) | 2018-12-21 | 2024-08-29 | インスリン及びグルカゴンを含む薬学組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022514835A JP2022514835A (ja) | 2022-02-16 |
| JP2022514835A5 true JP2022514835A5 (https=) | 2023-01-06 |
Family
ID=71102651
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021534266A Pending JP2022514835A (ja) | 2018-12-21 | 2019-12-23 | インスリン及びグルカゴンを含む薬学組成物 |
| JP2024147410A Pending JP2024178193A (ja) | 2018-12-21 | 2024-08-29 | インスリン及びグルカゴンを含む薬学組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024147410A Pending JP2024178193A (ja) | 2018-12-21 | 2024-08-29 | インスリン及びグルカゴンを含む薬学組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220064248A1 (https=) |
| EP (1) | EP3900734A4 (https=) |
| JP (2) | JP2022514835A (https=) |
| KR (1) | KR20200078414A (https=) |
| CN (1) | CN113365651A (https=) |
| AU (1) | AU2019405389B2 (https=) |
| BR (1) | BR112021011557A2 (https=) |
| CA (1) | CA3124340A1 (https=) |
| MX (1) | MX2021007124A (https=) |
| WO (1) | WO2020130751A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113453703A (zh) * | 2018-12-21 | 2021-09-28 | 韩美药品株式会社 | 包括胰岛素和对胰高血糖素和glp-1和gip受体均具有活性的三重激动剂的药物组合物 |
| EP4183407A4 (en) * | 2020-07-15 | 2024-08-14 | Hanmi Pharm. Co., Ltd. | THERAPEUTIC USE OF A GLUCAGNONE DERIVATIVE OR CONJUGATE THEREOF FOR LIVER DISEASES |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6096871A (en) | 1995-04-14 | 2000-08-01 | Genentech, Inc. | Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life |
| JP4046354B2 (ja) | 1996-03-18 | 2008-02-13 | ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム | 増大した半減期を有する免疫グロブリン様ドメイン |
| US7314859B2 (en) * | 2002-12-27 | 2008-01-01 | Diobex, Inc. | Compositions and methods for the prevention and control of insulin-induced hypoglycemia |
| AR081066A1 (es) * | 2010-04-02 | 2012-06-06 | Hanmi Holdings Co Ltd | Conjugado de insulina donde se usa un fragmento de inmunoglobulina |
| KR20140043709A (ko) * | 2011-01-20 | 2014-04-10 | 질랜드 파마 에이/에스 | 아실화 글루카곤 유사체와 인슐린 유사체의 조합 |
| DK2963056T3 (da) | 2013-02-26 | 2020-02-17 | Hanmi Pharm Ind Co Ltd | Insulinanalog og anvendelse deraf |
| AR100695A1 (es) * | 2014-05-30 | 2016-10-26 | Hanmi Pharm Ind Co Ltd | Composición para el tratamiento de diabetes mellitus que comprende insulina y un agonista dual glp-1 / glucagón |
| WO2015189698A2 (en) | 2014-06-08 | 2015-12-17 | Beijing Cosci-Remd Bio Med Tech Company Ltd | Methods for treating type 1 diabetes using glucagon receptor antagonistic antibodies |
| PE20171154A1 (es) * | 2014-12-30 | 2017-08-16 | Hanmi Pharm Ind Co Ltd | Derivados de glucagon con estabilidad mejorada |
| EP4523705A3 (en) * | 2015-06-30 | 2025-06-11 | Hanmi Pharm. Co., Ltd. | Glucagon derivative and a composition comprising a long acting conjugate of the same |
| UY36870A (es) | 2015-08-28 | 2017-03-31 | Hanmi Pharm Ind Co Ltd | Análogos de insulina novedosos |
| WO2017052329A1 (en) * | 2015-09-24 | 2017-03-30 | Hanmi Pharm. Co., Ltd. | Protein complex by use of a specific site of an immunoglobulin fragment for linkage |
| TW201718629A (zh) * | 2015-09-25 | 2017-06-01 | 韓美藥品股份有限公司 | 包含多個生理多肽及免疫球蛋白Ｆｃ區之蛋白質接合物 |
| EP3479841A4 (en) * | 2016-06-29 | 2020-03-04 | Hanmi Pharm. Co., Ltd. | GLUCAGON DERIVATIVE, CONJUGATE THEREOF, COMPOSITION THEREOF AND THERAPEUTIC USE THEREOF |
| WO2018144867A1 (en) * | 2017-02-03 | 2018-08-09 | Vanderbilt University | Systems, compositions and methods for treating diabetes |
| CN110545849A (zh) * | 2017-02-03 | 2019-12-06 | 韩美药品株式会社 | 具有增加的持续性的生理活性物质的缀合物及其应用 |
| GB201710822D0 (en) * | 2017-07-05 | 2017-08-16 | Zealand Pharma As | Methods and medical uses relating to the treatment of hypoglycaemia |
-
2019
- 2019-12-23 KR KR1020190173205A patent/KR20200078414A/ko active Pending
- 2019-12-23 CA CA3124340A patent/CA3124340A1/en active Pending
- 2019-12-23 BR BR112021011557-9A patent/BR112021011557A2/pt unknown
- 2019-12-23 AU AU2019405389A patent/AU2019405389B2/en active Active
- 2019-12-23 EP EP19897547.6A patent/EP3900734A4/en active Pending
- 2019-12-23 CN CN201980090567.3A patent/CN113365651A/zh active Pending
- 2019-12-23 MX MX2021007124A patent/MX2021007124A/es unknown
- 2019-12-23 WO PCT/KR2019/018320 patent/WO2020130751A1/ko not_active Ceased
- 2019-12-23 JP JP2021534266A patent/JP2022514835A/ja active Pending
- 2019-12-23 US US17/415,474 patent/US20220064248A1/en active Pending
-
2024
- 2024-08-29 JP JP2024147410A patent/JP2024178193A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019504055A5 (https=) | ||
| CN107106660B (zh) | 长效glp-1/胰高血糖素受体双激动剂对于治疗非酒精性脂肪肝疾病的应用 | |
| JP6749845B2 (ja) | インスリン及びｇｌｐ−１／グルカゴン二重アゴニストを含む糖尿病治療用組成物 | |
| JP6877478B2 (ja) | 増殖分化因子１５（ｇｄｆ−１５）の構築物 | |
| JP2019524675A5 (https=) | ||
| TWI388570B (zh) | 包含具有三個官能端的非肽醯聚合物的多肽複合物 | |
| JP7596268B2 (ja) | グルカゴン、ｇｌｐ－１及びｇｉｐ受容体の全てに活性を有する三重活性体と、インスリンとを含む薬学組成物 | |
| JP2021167352A (ja) | 免疫グロブリンＦｃフラグメント結合を用いたタンパク質及びペプチドの溶解度を改善する方法 | |
| RU2009129953A (ru) | Инсулинотропный комплекс, в котором использован фрагмент иммуноглобулина | |
| JP2022551282A5 (https=) | ||
| EA038524B1 (ru) | Длительно действующий конъюгат тройного агониста рецепторов глюкагона/glp 1/gip | |
| CN107810202A (zh) | 长效胰岛素或胰岛素类似物复合物 | |
| JP2022514835A5 (https=) | ||
| RU2015138536A (ru) | Новый аналог инсулина и его применение | |
| RU2016147505A (ru) | Конъюгат, содержащий оксинтомодулин и фрагмент иммуноглобулина, и его применение | |
| JP2016519569A5 (https=) | ||
| JP2015510880A5 (https=) | ||
| JP2020512287A5 (https=) | ||
| JP2024178193A (ja) | インスリン及びグルカゴンを含む薬学組成物 | |
| IL293745A (en) | Bifunctional molecules comprising an il-7 variant | |
| RU2021116078A (ru) | Фармацевтическая композиция, содержащая инсулин и глюкагон | |
| RU2019131593A (ru) | Комплекс аналога инсулина со сниженной аффинностью к инсулиновому рецептору и его применение | |
| CN114984231B (zh) | 稳定性制剂及其制备方法 | |
| RU2847194C1 (ru) | Жидкая композиция длительно действующего конъюгата тройного агониста глюкагона, GLP-1 И GIP | |
| RU2823246C2 (ru) | Фармацевтическая композиция, содержащая инсулин и глюкагон |